Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
ERAS
ERAS News & Events
-
Add to Watchlist
Trade ERAS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
ERAS News
Revolution's Cancer Drug Shows Promising Results in Trials
Apr 13 2026
stocktwits
Erasca Inc Shares Surpass Analyst Target Price
Apr 03 2026
NASDAQ.COM
ImmunityBio's Anktiva Receives EU Approval, Boosting Stock
Apr 01 2026
stocktwits
Erasca CMO Sells Shares Under 10b5-1 Plan
Mar 26 2026
NASDAQ.COM
Erasca CMO Sells Shares in SEC Filing
Mar 26 2026
Fool
Erasca Reports Q4 2025 Financial Results with Reduced Losses
Mar 12 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Mar 06 2026
Benzinga
Tango Therapeutics Shares Surge 24% to New 52-Week High Following Collaboration with Erasca
Mar 05 2026
seekingalpha
Show More News
ERAS Events
04/13 12:10
Erasca Shares Down 7.9% to $15.66
Erasca is down -7.9%, or -$1.35 to $15.66.
04/13 12:10
Erasca Shares Drop 9% to $15.54 After Revolution Pancreatic Cancer Data
Erasca drops 9% to $15.54 after Revolution pancreatic cancer data
04/13 10:10
Erasca Shares Drop 10.6% to $15.20
Erasca is down -10.6%, or -$1.81 to $15.20.
Show More Events
ERAS Monitor News
Erasca Inc. hits 5-day low amid market stability
Apr 13 2026
Erasca Inc. Closes $258.8 Million Upsized Public Offering
Jan 26 2026
Erasca's General Counsel Sells Shares Amid Market Confidence
Jan 15 2026
Erasca Inc Surpasses Analyst Target Price, Stock Rises
Jan 09 2026
Erasca Inc Surges After Analyst Upgrade
Jan 07 2026
ERAS Earnings Analysis
No Data
People Also Watch
